MedTrace Logo

Thriving, Activity and Social Participation After Stroke

NCT00495248 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2011-08-09

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of a group intervention programme for community dwelling elders with stroke or TIA.The intervention is inspired by a Lifestyle Redesign method developed in the USA. The study is conducted as a multi centre randomized controlled trial. Participants are recruited from five hospitals and the intervention is implemented at six to seven senior centres. The control group is offered physical activity at the senior centre once a week. The intervention group is offered the same with addition of the programme inspired by Lifestyle Redesign. The study will contribute to knowledge whether the intervention will promote social participation and thriving in daily life and prevent social isolation and depressive symptoms among community dwelling elders with stroke or TIA.

Conditions

Interventions

BEHAVIORAL

Group intervention inspired by Lifestyle Redesign

Group intervention inspired by Lifestyle Redesign

BEHAVIORAL

Group intervention inspired by Lifestyle redesign

Lifestyle programme once a week for two hours over an intervention period of 9 months

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • The Norwegian Women´s Public Health Association

    collaborator OTHER

  • Ullevaal University Hospital

    lead OTHER

Principal Investigators

  • Unni Sveen, PhD · Ullevaal University Hospital ,Medical division, research Unit 0407 Oslo Norway

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-09-30
Completion
2011-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00495248 on ClinicalTrials.gov